 NEWTON, Mass., June 08, 2021 GLOBE NEWSWIRE -- Allena Pharmaceuticals, Inc. NASDAQ:ALNA, a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced the granting of an inducement award to a new employee. In accordance with NASDAQ Listing Rule 5635c4, the award was made as a material inducement to the employees entry into employment with the Company. 